Cancer and Hematology Clinical Research Program
1 / 1

Cancer and Hematology Clinical Research Program

Author : debby-jeon | Published Date : 2025-06-27

Description: Cancer and Hematology Clinical Research Program and Translational Research Core About the CHCRP Founded in 1991 Cancer and Hematologybased Trials Cancer Treatment Prevention or Early Detection Symptom Management symptoms caused by

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Cancer and Hematology Clinical Research Program" is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Transcript:Cancer and Hematology Clinical Research Program:
Cancer and Hematology Clinical Research Program and Translational Research Core About the CHCRP Founded in 1991 Cancer and Hematology-based Trials: Cancer Treatment, Prevention or Early Detection Symptom Management (symptoms caused by disease or by treatments) Quality of Life of cancer patients Cancer Care Delivery (examples: Patient Navigation, Disparities, compliance tools) Pre-clinical Research (cellular and molecular studies) Scope of Cancer Research Cancer Research is not limited to oncology programs. Cancer can be an area of research in many different fields: All cancer research from ANY department must be reviewed by the cancer program. This includes any trial involving patients with cancer or trials relating to cancer prevention or detection. Ideally this should be done early in the process to obtain guidance and to avoid delays. IRB applications for all studies involving cancer must be routed to Dr. Kulke in INSPIR for review and sign-off. Translational Research Core (TRC) The TRC has recently been developed to allow researchers to obtain specimens and data for their research. Proposals must be submitted to Dr. Kulke for review and approval. How CHCRP can be a resource to others Infrastructure in place with experience in: Conducting complex clinical trials Recruiting, consenting and enrolling diverse population utilizing available resources (interpreter use, patient navigation, individualized participant education, confirming understanding & compliance ability) Resource utilization – frequent assessment of program needs/workloads Successful audits Each audit is considered a valuable learning experience, allowing us to incorporate new ideas into our standard procedures Expertise in utilizing Velos to ensure research billing compliance Regulatory Requirements Budget development/anticipating needs Protocol development (including ICFs, patient materials and protocol coordination tools) Resources bumc.bu.edu/clinicaltrials Site is updated monthly and includes: Program Contact Information Current list of active clinical and non-clinical trials Enrollment and Status Update Forms

Download Document

Here is the link to download the presentation.
"Cancer and Hematology Clinical Research Program"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Presentations

Creating a Benign Hematology Curriculum BIOGRAPHICALSKETCH Course Proposal: Methods in Clinical Cancer Research Hematology Donna  O’Niell Welcome to UNC Hematology/Oncology! How to Engage Fellows in Benign Hematology The Clinical Laboratory and the Hematologist Hematology and  Chemistry Laboratory Male breast cancer Meyskens Jr and Janaes Cancer Section Cancer Ins HematologyOncology The Tata Medical Center Fellowship Program in Pediatric Hematology NUTRITIONAL ANEMIAS: a focus on Iron Deficiency Program Directors Survey